U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684937) titled 'HL-300 Ointment in Healthy Volunteers' on June 01.
Brief Summary: To evaluate the safety and tolerability of HL-300 ointment following single and multiple topical administrations in healthy Chinese adult volunteers.
Study Start Date: June 14, 2024
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Intervention:
DRUG: HL-300
Number of Healthy Volunteers:4 (Treatment group: 3, Placebo*: 1)
DRUG: HL-300
Number of Healthy Volunteers:8 (Treatment group: 6, Placebo: 2);Dosing Days:Day 1;
DRUG: HL-300
Number of Healthy Volunteers:12 (Treatment group: 10, Placebo: 2);Dosing Days:Day 1
DRUG: HL-300
Number of Healthy Voluntee...